// App-Quantinova.ai

AB0089 (2021) : SILDENAFIL COUNTERACTS THE ACTIVATION OF CXCR3/CXCL10, -11 AXIS IN SCLERODERMA FIBROBLASTS EXPOSED TO REACTIVE OXYGEN SPECIES

Researchers

Presenter

  • C. Antinozzi

Principal Investigators

  • F. Del Galdo

Medical Centers

  • University of Rome Foro Italico, Movement, Human and Health Sciences, Rome, Italy

  • University of Leeds, Leeds Institue of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom

  • NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom

Locations

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • C-X-C motif chemokine 10

  • C-X-C motif chemokine receptor 3

Drug/Treatment

  • Hydrogen peroxide

  • Sildenafil citrate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved